for subscribers

Covid-19 and ivermectin: How doctors have reacted to SAHPRA’s ‘compassionate-use’ programme

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
 A general view of the drug Ivermectin.
A general view of the drug Ivermectin.
(Photo by Gallo Images/Ziyaad Douglas)

 Ivermectin, an anti-parasitic drug, has generated significant attention as of late as a possible Covid-19 treatment after some trials showed promising results.

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
Lockdown For
DAYS
HRS
MINS
Voting Booth
When a Covid-19 vaccine for under 16's becomes available, will you be taking your children to get it?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, immediately!
38% - 3764 votes
I'll wait to see how others respond
26% - 2552 votes
No, I don't think they need it
37% - 3649 votes
Vote
ZAR/USD
15.30
(-1.60)
ZAR/GBP
21.24
(-1.18)
ZAR/EUR
18.31
(-0.77)
ZAR/AUD
11.82
(-1.06)
ZAR/JPY
0.14
(-0.68)
Gold
1697.41
(-0.76)
Silver
25.33
(-2.55)
Platinum
1126.50
(-2.63)
Brent Crude
63.94
(+2.19)
Palladium
2335.00
(+0.34)
All Share
67743.54
(-0.85)
Top 40
62250.03
(-0.97)
Financial 15
12674.59
(+0.82)
Industrial 25
87893.58
(-1.99)
Resource 10
69264.74
(+0.06)
All JSE data delayed by at least 15 minutes morningstar logo